TherapeuticsMD Inc (OQ:TXMD)

Business Focus: Specialty & Advanced Pharmaceuticals

Latest 10 SEC filings (by transaction date) for TXMD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 29th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 7/23 Dec 7/23 Walker Marlan D Direct Ownership Common Stock S - Open market or private sale -4,550 $2.24
Dec 7/23 Dec 6/23 Walker Marlan D Direct Ownership Common Stock S - Open market or private sale -14,500 $2.31
Dec 7/23 Dec 5/23 Walker Marlan D Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -70,000  
Dec 7/23 Dec 5/23 Walker Marlan D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 70,000  
Nov 17/23 Nov 15/23 Rubric Capital Management LP Indirect Ownership Common Stock, par value $0.001 per share ("Common Stock") A - Grant, award or other under Rule 16b-3(d) 877,192 $2.28
Aug 21/23 Aug 17/23 Ziegler Joseph Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 7,500  
Jul 19/23 Jul 17/23 Thompson Tommy G Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 8,500  
Jul 19/23 Jul 17/23 Naughton Gail K Direct Ownership Restricted Stock Unit A - Grant, award or other under Rule 16b-3(d) 8,500  
Jul 19/23 Jul 17/23 Collins Cooper C. Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 8,500  
Jun 29/23 Jun 28/23 Rubric Capital Management LP Indirect Ownership Common Stock, par value $0.001 per share ("Common Stock") A - Grant, award or other under Rule 16b-3(d) 312,525 $3.68
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for TXMD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 29th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 7/23 Dec 5/23 Walker Marlan D Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -70,000  
Dec 7/23 Dec 7/23 Walker Marlan D Direct Ownership Common Stock S - Open market or private sale -4,550 $2.24
Dec 7/23 Dec 6/23 Walker Marlan D Direct Ownership Common Stock S - Open market or private sale -14,500 $2.31
Dec 7/23 Dec 5/23 Walker Marlan D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 70,000  
Nov 17/23 Nov 15/23 Rubric Capital Management LP Indirect Ownership Common Stock, par value $0.001 per share ("Common Stock") A - Grant, award or other under Rule 16b-3(d) 877,192 $2.28
Aug 21/23 Aug 17/23 Ziegler Joseph Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 7,500  
Jul 19/23 Jul 17/23 Thompson Tommy G Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 8,500  
Jul 19/23 Jul 17/23 Naughton Gail K Direct Ownership Restricted Stock Unit A - Grant, award or other under Rule 16b-3(d) 8,500  
Jul 19/23 Jul 17/23 Collins Cooper C. Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 8,500  
Jun 29/23 Jun 28/23 Rubric Capital Management LP Indirect Ownership Common Stock, par value $0.001 per share ("Common Stock") A - Grant, award or other under Rule 16b-3(d) 312,525 $3.68
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $TXMD

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Supernus Pharmaceuticals (OQ:SUPN)
Eagle Pharmaceuticals (OQ:EGRX)
CorMedix (OQ:CRMD)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.